APGE - Apogee Therapeutics, Inc. Common Stock
Apogee Therapeutics, Inc. Common Stock Logo

APGE - Apogee Therapeutics, Inc. Common Stock

https://www.apogeetherapeutics.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
As of 2025-09-10 (Snapshot)

Apogee Therapeutics, Inc., through its subsidiary, is a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company is headquartered in Waltham, Massachusetts.

52W High
$63.50
52W Low
$26.20
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.43
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
N/A
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
3.64
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
7.60%
Institutions (25–75% balanced)
132.46%
Shares Outstanding
46,109,800
Float
37,785,500
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
0
EPS (TTM)
-4.14
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-0.34%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Bearish momentum
Value
-0.0886
Previous
-0.0091
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025